Flow Diverters Market Expected to Surpass USD $0.85 Billion by 2029, Expanding at 11.5% CAGR

 Get 20% Off Market Intelligence Reports With Code ONLINE20 — Track Global Tariffs, Economic Shifts, and Sector Transformations

 

 How Will the Market Growth Rate of the Flow Diverters Market Impact Future Demand?
 The flow diverters market size has grown rapidly in recent years. It will grow from $0.5 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing prevalence of intracranial aneurysms worldwide, rising adoption of endovascular procedures, growing awareness among physicians and patients, rising healthcare expenditure globally, growing preference for minimally invasive and outpatient procedures.
 
 The flow diverters market size is expected to see rapid growth in the next few years. It will grow to $0.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to an increasing number of favorable clinical outcomes and real-world evidence, rising investments in research and development, a growing geriatric population, increasing reimbursement coverage, increasing incidence of hypertension, and atherosclerosis. Major trends in the forecast period include advancements in flow diverter device design, integration of advanced imaging techniques, technology improvements in bioabsorbable and biocompatible materials, advancements in delivery systems, and developments in personalized medicine.
 
 Claim your free report sample now:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24539&type=smp
 
 What Are the Key Factors Contributing to Flow Diverters Market Growth?
 The rising prevalence of aneurysms is expected to propel the growth of the flow diverters market going forward. Aneurysms refer to abnormal bulges or ballooning in the wall of a blood vessel, typically caused by weakening of the vessel wall. The increase in prevalence of aneurysms is driven by a rising aging population and improved diagnostic technologies, as they lead to higher detection rates and greater awareness, thereby increasing the number of diagnosed cases. Flow diverters help address the rising prevalence of aneurysms by redirecting blood flow away from the weakened vessel area, promoting healing, reducing the risk of rupture, and offering a minimally invasive alternative to traditional surgical treatments. For instance, in February 2022, according to the Brain Aneurysm Foundation, a U.S.-based advocacy organization, an estimated 6.5 million Americans, roughly 1 in 50, have an unruptured brain aneurysm, with about 30,000 experiencing a rupture annually. Therefore, the rising prevalence of aneurysms is driving the growth of the flow diverters market.
 
 What Are the Core Segments Shaping the Flow Diverters Market Landscape?
 The flow diverters market covered in this report is segmented — 
 
 1) By Type: Pipeline Embolization Device, Silk Flow Diverter, Surpass Flow Diverter, Flow Redirection Endoluminal Device, Other Types
 2) By Material: Nitinol, Cobalt-Chromium Alloy, Stainless Steel, Other Materials
 3) By Application: Intracranial Aneurysms, Arteriovenous Malformations, Carotid Artery Disease, Other Applications
 4) By End-User: Hospital And Clinics, Ambulatory Surgical Centre
 
 Subsegments:
 1) By Pipeline Embolization Device: Classic Pipeline Embolization Device, Pipeline Flex Embolization Device, Pipeline Shield Technology
 2) By Silk Flow Diverter: Silk+ Flow Diverter, Silk Vista Baby
 3) By Surpass Flow Diverter: Surpass Streamline, Surpass Evolve
 4) By Flow Redirection Endoluminal Device: FRED Jr., FRED X
 5) By Other Types: DERIVO Embolization Device, p64 Flow Modulation Device, Tubridge Flow Diverter
 
 What Are the Significant Trends in the Flow Diverters Market Across Regions?
 Major companies operating in the flow diverters market are focusing on advancements in material science, such as polymer-based neurovascular stents, to enhance device performance, improve biocompatibility, promote natural vessel healing, and reduce the need for long-term blood-thinning medication. A polymer-based neurovascular stent is a medical implant designed to support and maintain the patency of blood vessels in the brain (neurovasculature), particularly in the treatment of conditions such as aneurysms, stenosis, or vascular malformations. For instance, in June 2023, Fluid Biomed, a Canada-based medical device start-up, announced the world’s first implantation of a polymer-based neurovascular stent in human patients. This innovative device, known as the ReSolv stent, is specifically designed to treat brain aneurysms. Unlike traditional hybrid polymer-metal stents, the ReSolv stent is entirely polymer-based and is engineered to gradually dissolve as the blood vessel heals. This unique design has the potential to minimize the need for long-term blood-thinning medication while supporting the natural healing process of the vessel.
 
 Which Players Dominate the Flow Diverters Market Landscape?
 Major companies operating in the flow diverters market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Penumbra Inc., Phenox GmbH, Sino Medical Sciences Technology Inc., Balt Extrusion S.A.S., Sequent Medical Inc., Wallaby Medical Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Acandis GmbH & Co. KG, Fluid Biomed Inc., InspireMD Inc., INVAMED Medical Innovation, Oxford Endovascular Ltd., Qvanteq AG, EndoStream Medical Ltd., Endomimetics LLC. 
 
 Get the full flow diverters market report here:
 https://www.thebusinessresearchcompany.com/report/flow-diverters-global-market-report
 
 What Are the Regional Insights for the Flow Diverters Market Forecast?
 North America was the largest region in the flow diverters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the flow diverters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company